# RADA16 for Aquablation Day Case

> **NCT06948331** · PHASE2 · NOT_YET_RECRUITING · sponsor: **NYU Langone Health** · enrollment: 25 (estimated)

## Conditions studied

- Hematuria
- Benign Prostatic Hyperplasia
- Lower Urinary Tract Symptoms

## Interventions

- **DEVICE:** PuraStat

## Key facts

- **NCT ID:** NCT06948331
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06948331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06948331, "RADA16 for Aquablation Day Case". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06948331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*